Forterra Inc  

(Public, NASDAQ:FRTA)   Watch this stock  
Find more results for FRTA
4.46
-0.11 (-2.41%)
After Hours: 4.46 0.00 (0.00%)
Aug 18, 4:28PM EDT  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 4.39 - 4.63
52 week 3.19 - 22.76
Open 4.50
Vol / Avg. 1.01M/1.14M
Mkt cap 286.35M
P/E     -
Div/yield     -
EPS -1.41
Shares 64.20M
Beta     -
Inst. own 102%

Key stats and ratios

Q2 (Jun '17) 2016
Net profit margin -2.56% -0.81%
Operating margin 0.52% 4.63%
EBITD margin - 12.80%
Return on average assets -2.32% -0.80%
Return on average equity -42.43% -11.97%
Employees 5,353 -
CDP Score - -

Address

511 E John Carpenter Fwy Ste 600
IRVING, TX 75062-3930
United States - Map
+1-469-4587973 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Forterra, Inc. is a manufacturer of pipe and precast products. The Company offers products for a range of water-related infrastructure applications, including water transmission, distribution and drainage. The Company operates approximately 95 facilities. Its products are available in the United States and Eastern Canada.

Officers and directors

Chris Meyer Chairman of the Board
Age: 46
Bio & Compensation  - Reuters
Jeffrey Bradley Chief Executive Officer, Director
Age: 56
Bio & Compensation  - Reuters
William Matthew Brown Chief Financial Officer, Executive Vice President
Age: 52
Bio & Compensation  - Reuters
Mark Carpenter President - Drainage Pipe & Products
Age: 48
Bio & Compensation  - Reuters
William Kerfin President - Water Pipe & Products
Age: 49
Bio & Compensation  - Reuters
Lori M. Browne Senior Vice President, General Counsel
Age: 42
Bio & Compensation  - Reuters
Ed Sexe Senior Vice President, General Manager
Age: 52
Bio & Compensation  - Reuters
Matthew Wayman Vice President - Corporate Development
Age: 37
Bio & Compensation  - Reuters
Kevin J. Barner Director Nominee
Age: 35
Bio & Compensation  - Reuters
Robert J. Corcoran Director Nominee
Age: 57
Bio & Compensation  - Reuters